307 related articles for article (PubMed ID: 35371096)
21. LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma.
Wei Q; Liu G; Huang Z; Huang Y; Huang L; Huang Z; Wu X; Wei H; Pu J
J Hepatocell Carcinoma; 2023; 10():1019-1035. PubMed ID: 37435155
[TBL] [Abstract][Full Text] [Related]
22. Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization.
Wang B; Li X; Hu W; Zhou Y; Din Y
IUBMB Life; 2019 Dec; 71(12):1952-1961. PubMed ID: 31408278
[TBL] [Abstract][Full Text] [Related]
23. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
24. Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M2.
Zhou J; Che J; Xu L; Yang W; Zhou W; Zhou C
Dig Liver Dis; 2022 Apr; 54(4):543-553. PubMed ID: 34497040
[TBL] [Abstract][Full Text] [Related]
25.
Li C; Pan XY; Ma M; Zhao J; Zhao F; Lv YP
Pharm Biol; 2021 Dec; 59(1):1533-1539. PubMed ID: 34726570
[TBL] [Abstract][Full Text] [Related]
26. Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinoma.
Gao Z; Li XG; Feng SR; Chen JF; Song K; Shi YH; Tang Z; Liu WR; Zhang X; Huang A; Luo XM; Zeng HY; Gao Q; Shi GM; Ke AW; Zhou J; Fan J; Fu XT; Ding ZB
Int Immunopharmacol; 2023 Oct; 123():110685. PubMed ID: 37494837
[TBL] [Abstract][Full Text] [Related]
27. Phellinus linteus activates Treg cells via FAK to promote M2 macrophage polarization in hepatocellular carcinoma.
Chen F; Gong M; Weng D; Jin Z; Han G; Yang Z; Han J; Wang J
Cancer Immunol Immunother; 2024 Jan; 73(1):18. PubMed ID: 38240856
[TBL] [Abstract][Full Text] [Related]
28. Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway.
Min L; Wang H; Qi H
Am J Transl Res; 2022; 14(3):1551-1566. PubMed ID: 35422920
[TBL] [Abstract][Full Text] [Related]
29. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of ten zinc (Zn) transporter genes and their regulation to Zn metabolism in freshwater teleost yellow catfish Pelteobagrus fulvidraco.
Chen SW; Wu K; Lv WH; Song CC; Luo Z
J Trace Elem Med Biol; 2020 May; 59():126433. PubMed ID: 31735605
[TBL] [Abstract][Full Text] [Related]
31. MyD88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization.
Liu Y; Chen H; Yan X; Zhang J; Deng Z; Huang M; Gu J; Zhang J
Cell Commun Signal; 2024 Jan; 22(1):86. PubMed ID: 38291436
[TBL] [Abstract][Full Text] [Related]
32. Exosomes synergized with PIONs@E6 enhance their immunity against hepatocellular carcinoma via promoting M1 macrophages polarization.
Chen H; Jiang S; Zhang P; Ren Z; Wen J
Int Immunopharmacol; 2021 Oct; 99():107960. PubMed ID: 34284286
[TBL] [Abstract][Full Text] [Related]
33. SLAMF6/Ly108 promotes the development of hepatocellular carcinoma via facilitating macrophage M2 polarization.
Meng Q; Duan X; Yang Q; Xue D; Liu Z; Li Y; Jin Q; Guo F; Jia S; Wang Z; Yan W; Chang X; Sun P
Oncol Lett; 2022 Mar; 23(3):83. PubMed ID: 35126725
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA GAS5 overexpression inhibits M2-like polarization of tumour-associated macrophages in SMCC-7721 cells by promoting PTEN expression.
Wang X; Li FY; Zhao W; Gao ZK; Shen B; Xu H; Cui YF
Int J Exp Pathol; 2020 Dec; 101(6):215-222. PubMed ID: 33146930
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
36. TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells.
Chen Y; Wen H; Zhou C; Su Q; Lin Y; Xie Y; Huang Y; Qiu Q; Lin J; Huang X; Tan W; Min C; Wang C
Exp Cell Res; 2019 May; 378(1):41-50. PubMed ID: 30844387
[TBL] [Abstract][Full Text] [Related]
37. Tramadol suppresses growth of orthotopic liver tumors via promoting M1 macrophage polarization in the tumor microenvironment.
Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4205-4218. PubMed ID: 38041778
[TBL] [Abstract][Full Text] [Related]
38. Disruption of SLFN11 Deficiency-Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti-PD-1 Therapy Efficacy in Hepatocellular Carcinoma.
Zhou C; Weng J; Liu C; Liu S; Hu Z; Xie X; Gao D; Zhou Q; Sun J; Xu R; Li H; Shen Y; Yi Y; Shi Y; Sheng X; Dong Q; Hung MC; Ren N
Gastroenterology; 2023 Jun; 164(7):1261-1278. PubMed ID: 36863689
[TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase 2 regulates STAT1-dependent upregulation of atypical chemokine receptor 3 to induce M2 macrophage migration and immune escape in hepatocellular carcinoma.
Chen F; Yang L; Peng X; Mao M; Liu X; Song J; Hu J
Mol Immunol; 2022 Nov; 151():204-217. PubMed ID: 36179603
[TBL] [Abstract][Full Text] [Related]
40. GdCl3 suppresses the malignant potential of hepatocellular carcinoma by inhibiting the expression of CD206 in tumor‑associated macrophages.
Zhu F; Li X; Jiang Y; Zhu H; Zhang H; Zhang C; Zhao Y; Luo F
Oncol Rep; 2015 Nov; 34(5):2643-55. PubMed ID: 26352004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]